Thrombosis Drugs Market Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 - 2025

Jul 2018| TMR731A| Transparency

Report Highlights

Global Thrombosis Drugs Market: Overview
Thrombosis drugs help in the prevention or inhibition of thrombus, by mimicking the role of antithrombin, a protein molecule produced in the body, which helps clotting of the blood. Antithrombin is a small protein involved in the inactivation of several enzymes in the coagulation system. The global thrombosis drugs market is expanding at a significant pace due to factors such as increase in the cases of cancer and the number of patients consuming high amounts of tobacco, worldwide.

The global thrombosis drugs market report comprises an elaborate executive summary, which includes a market snapshot that provides information about various segments of the market. It also provides information and data analysis of the global market with respect to the segments based on drug class, indication, distribution channel, and region. A detailed qualitative analysis of drivers, restraints, and opportunities have been provided in the market overview section. Additionally, the section comprises competitive matrix and company profiles with business overview to understand competitive landscape in the market. This section of the report also provides market attractiveness analysis, by geography, and market share analysis by key players, thus presenting a thorough analysis of the overall competitive scenario in the global thrombosis drugs market.

Global Thrombosis Drugs Market: Key Segments
Based on drug class, the global thrombosis drugs market can be segmented into factor Xa inhibitor, low molecular weight heparin, p2y12 platelet inhibitor, and others. The drug class in this segment have been analyzed based on different uses of drugs to treat thrombosis events in various regions. The market size and forecast for each of these segments have been provided for the period from 2016 to 2026, along with their respective CAGRs for the forecast period from 2018 to 2026, considering 2017 as the base year. In terms of indication, the global thrombosis drugs market can be classified into pulmonary embolism, atrial fibrillation, deep vein thrombosis, and others. The market size and forecast for each of these segments have been provided for the period from 2016 to 2026, along with their respective CAGRs for the period from 2018 to 2026, considering 2017 as the base year.

Global Thrombosis Drugs Market: Regional Outlook
In terms of geography, the global thrombosis drugs market has been categorized into five major regions and the key countries in the respective region: North America (the U.S. and Canada), Europe (the U.K., Germany, France, Italy, Spain, and Rest of Europe), Asia Pacific (China, Japan, India, Australia & New Zealand, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and Middle East & Africa (GCC Countries, South Africa, Israel, and Rest of MEA). The market size and forecast for each of these regions and the mentioned countries have been provided for the period from 2016 to 2026, along with their respective CAGRs for the period from 2018 to 2026, considering 2017 as the base year. The research study also provides the competitive scenario in these regions.

Companies Mentioned in Report
The report also profiles major players in the market and provides various attributes such as company overview, financial overview, drug class portfolios, business strategies, and recent developments. Major companies profiled in the thrombosis drugs market include GlaxoSmithKline plc, Baxter International Inc., Johnson & Johnson, Sanofi, Bristol-Myers Squibb Company, AstraZeneca plc, Bayer AG, Aspen Pharmacare Holdings Limited, Boehringer Ingelheim GmbH, and Pfizer, Inc.

The global thrombosis drugs market has been segmented as follows:

Thrombosis Drugs Market, by Drug Class
Factor Xa Inhibitor
Low Molecular Weight Heparin
P2Y12 Platelet Inhibitor
Others

Thrombosis Drugs Market, by Indication
Pulmonary Embolism
Atrial Fibrillation
Deep Vein Thrombosis
Others

Thrombosis Drugs Market, by Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Thrombosis Drugs Market, by Geography
North America
U.S.
Canada
Europe
Germany
U.K.
France
Italy
Spain
Rest of Europe
Asia Pacific
Japan
China
India
Australia & New Zealand
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East & Africa
GCC Countries
South Africa
Israel
Rest of Middle East & Africa

  • Table 1 : Global Thrombosis Drugs Market Size (US$ Mn) Forecast, by Drug Class, 2016–2026
  • Table 2 : Global Thrombosis Drugs Market Size (US$ Mn) Forecast, by Indication, 2016–2026
  • Table 3 : Global Thrombosis Drugs Market Size (US$ Mn) Forecast, by Distribution Channel, 2016–2026
  • Table 4 : Global Thrombosis Drugs Market Size (US$ Mn) Forecast, by Region, 2016–2026
  • Table 5 : North America Thrombosis Drugs Market Size (US$ Mn) Forecast, by Country, 2016–2026
  • Table 6 : North America Thrombosis Drugs Market Size (US$ Mn) Forecast, by Drug Class, 2016–2026
  • Table 7 : North America Thrombosis Drugs Market Size (US$ Mn) Forecast, by Indication, 2016–2026
  • Table 8 : North America Thrombosis Drugs Market Size (US$ Mn) Forecast, by Distribution Channel, 2016–2026
  • Table 9 : U.S. Thrombosis Drugs Market Size (US$ Mn) Forecast, by Drug Class, 2016–2026
  • Table 10 : U.S. Thrombosis Drugs Market Size (US$ Mn) Forecast, by Indication, 2016–2026
  • Table 11 : U.S. Thrombosis Drugs Market Size (US$ Mn) Forecast, by Distribution Channel, 2016–2026
  • Table 12 : Canada Thrombosis Drugs Market Size (US$ Mn) Forecast, by Drug Class, 2016–2026
  • Table 13 : Canada Thrombosis Drugs Market Size (US$ Mn) Forecast, by Indication, 2016–2026
  • Table 14 : Canada Thrombosis Drugs Market Size (US$ Mn) Forecast, by Distribution Channel, 2016–2026
  • Table 15 : Europe Thrombosis Drugs Market Size (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
  • Table 16 : Europe Thrombosis Drugs Market Size (US$ Mn) Forecast, Drug Class, 2016–2026
  • Table 17 : Europe Thrombosis Drugs Market Size (US$ Mn) Forecast, by Indication, 2016–2026
  • Table 18 : Europe Thrombosis Drugs Market Size (US$ Mn) Forecast, by Distribution Channel, 2016–2026
  • Table 19 : Germany Thrombosis Drugs Market Size (US$ Mn) Forecast, by Drug Class, 2016–2026
  • Table 20 : Germany Thrombosis Drugs Market Size (US$ Mn) Forecast, by Indication, 2016–2026
  • Table 21 : Germany Thrombosis Drugs Market Size (US$ Mn) Forecast, by Distribution Channel, 2016–2026
  • Table 22 : U.K. Thrombosis Drugs Market Size (US$ Mn) Forecast, by Drug Class, 2016–2026
  • Table 23 : U.K. Thrombosis Drugs Market Size (US$ Mn) Forecast, by Indication, 2016–2026
  • Table 24 : U.K. Thrombosis Drugs Market Size (US$ Mn) Forecast, by Distribution Channel, 2016–2026
  • Table 25 : France Thrombosis Drugs Market Size (US$ Mn) Forecast, by Drug Class, 2016–2026
  • Table 26 : France Thrombosis Drugs Market Size (US$ Mn) Forecast, by Indication, 2016–2026
  • Table 27 : France Thrombosis Drugs Market Size (US$ Mn) Forecast, by Distribution Channel, 2016–2026
  • Table 28 : Italy Thrombosis Drugs Market Size (US$ Mn) Forecast, by Drug Class, 2016–2026
  • Table 29 : Italy Thrombosis Drugs Market Size (US$ Mn) Forecast, by Indication, 2016–2026
  • Table 30 : Italy Thrombosis Drugs Market Size (US$ Mn) Forecast, by Distribution Channel, 2016–2026
  • Table 31 : Spain Thrombosis Drugs Market Size (US$ Mn) Forecast, by Drug Class, 2016–2026
  • Table 32 : Spain Thrombosis Drugs Market Size (US$ Mn) Forecast, by Indication, 2016–2026
  • Table 33 : Spain Thrombosis Drugs Market Size (US$ Mn) Forecast, by Distribution Channel, 2016–2026
  • Table 34 : Rest of Europe Thrombosis Drugs Market Size (US$ Mn) Forecast, by Drug Class, 2016–2026
  • Table 35 : Rest of Europe Thrombosis Drugs Market Size (US$ Mn) Forecast, by Indication, 2016–2026
  • Table 36 : Rest of Europe Thrombosis Drugs Market Size (US$ Mn) Forecast, by Distribution Channel, 2016–2026
  • Table 37 : Asia Pacific Thrombosis Drugs Market Size (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
  • Table 38 : Asia Pacific Thrombosis Drugs Market Size (US$ Mn) Forecast, by Drug Class, 2016–2026
  • Table 39 : Asia Pacific Thrombosis Drugs Market Size (US$ Mn) Forecast, by Indication, 2016–2026
  • Table 40 : Asia Pacific Thrombosis Drugs Market Size (US$ Mn) Forecast, by Distribution Channel, 2016–2026
  • Table 41 : China Thrombosis Drugs Market Size (US$ Mn) Forecast, by Drug Class, 2016–2026
  • Table 42 : China Thrombosis Drugs Market Size (US$ Mn) Forecast, by Indication, 2016–2026
  • Table 43 : China Thrombosis Drugs Market Size (US$ Mn) Forecast, by Distribution Channel, 2016–2026
  • Table 44 : Japan Thrombosis Drugs Market Size (US$ Mn) Forecast, by Drug Class, 2016–2026
  • Table 45 : Japan Thrombosis Drugs Market Size (US$ Mn) Forecast, by Indication, 2016–2026
  • Table 46 : Japan Thrombosis Drugs Market Size (US$ Mn) Forecast, by Distribution Channel, 2016–2026
  • Table 47 : India Thrombosis Drugs Market Size (US$ Mn) Forecast, by Drug Class, 2016–2026
  • Table 48 : India Thrombosis Drugs Market Size (US$ Mn) Forecast, by Indication, 2016–2026
  • Table 49 : India Thrombosis Drugs Market Size (US$ Mn) Forecast, by Distribution Channel, 2016–2026
  • Table 50 : Australia & New Zealand Thrombosis Drugs Market Size (US$ Mn) Forecast, by Drug Class, 2016–2026
  • Table 51 : Australia & New Zealand Thrombosis Drugs Market Size (US$ Mn) Forecast, by Indication, 2016–2026
  • Table 52 : Australia & New Zealand Thrombosis Drugs Market Size (US$ Mn) Forecast, by Distribution Channel, 2016–2026
  • Table 53 : Rest of Asia Pacific Thrombosis Drugs Market Size (US$ Mn) Forecast, by Drug Class, 2016–2026
  • Table 54 : Rest of Asia Pacific Thrombosis Drugs Market Size (US$ Mn) Forecast, by Indication, 2016–2026
  • Table 55 : Rest of Asia Pacific Thrombosis Drugs Market Size (US$ Mn) Forecast, by Distribution Channel, 2016–2026
  • Table 56 : Latin America Thrombosis Drugs Market Size (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
  • Table 57 : Latin America Thrombosis Drugs Market Size (US$ Mn) Forecast, by Drug Class, 2016–2026
  • Table 58 : Latin America Thrombosis Drugs Market Size (US$ Mn) Forecast, by Indication, 2016–2026
  • Table 59 : Latin America Thrombosis Drugs Market Size (US$ Mn) Forecast, by Distribution Channel, 2016–2026
  • Table 60 : Brazil Thrombosis Drugs Market Size (US$ Mn) Forecast, by Drug Class, 2016–2026
  • Table 61 : Brazil Thrombosis Drugs Market Size (US$ Mn) Forecast, by Indication, 2016–2026
  • Table 62 : Brazil Thrombosis Drugs Market Size (US$ Mn) Forecast, by Distribution Channel, 2016–2026
  • Table 63 : Mexico Thrombosis Drugs Market Size (US$ Mn) Forecast, by Drug Class, 2016–2026
  • Table 64 : Mexico Thrombosis Drugs Market Size (US$ Mn) Forecast, by Indication, 2016–2026
  • Table 65 : Mexico Thrombosis Drugs Market Size (US$ Mn) Forecast, by Distribution Channel, 2016–2026
  • Table 66 : Rest of Latin America Thrombosis Drugs Market Size (US$ Mn) Forecast, by Drug Class, 2016–2026
  • Table 67 : Rest of Latin America Thrombosis Drugs Market Size (US$ Mn) Forecast, by Indication, 2016–2026
  • Table 68 : Rest of Latin America Thrombosis Drugs Market Size (US$ Mn) Forecast, by Distribution Channel, 2016–2026
  • Table 69 : Middle East & Africa Thrombosis Drugs Market Size (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
  • Table 70 : Middle East & Africa Thrombosis Drugs Market Size (US$ Mn) Forecast, by Drug Class, 2016–2026
  • Table 71 : Middle East & Africa Thrombosis Drugs Market Size (US$ Mn) Forecast, by Indication, 2016–2026
  • Table 72 : Middle East & Africa Thrombosis Drugs Market Size (US$ Mn) Forecast, by Distribution Channel, 2016–2026
  • Table 73 : GCC Countries Thrombosis Drugs Market Size (US$ Mn) Forecast, by Drug Class, 2016–2026
  • Table 74 : GCC Countries Thrombosis Drugs Market Size (US$ Mn) Forecast, by Indication, 2016–2026
  • Table 75 : GCC Countries Thrombosis Drugs Market Size (US$ Mn) Forecast, by Distribution Channel, 2016–2026
  • Table 76 : South Africa Thrombosis Drugs Market Size (US$ Mn) Forecast, by Drug Class, 2016–2026
  • Table 77 : South Africa Thrombosis Drugs Market Size (US$ Mn) Forecast, by Indication, 2016–2026
  • Table 78 : South Africa Thrombosis Drugs Market Size (US$ Mn) Forecast, by Distribution Channel, 2016–2026
  • Table 79 : Israel Thrombosis Drugs Market Size (US$ Mn) Forecast, by Drug Class, 2016–2026
  • Table 80 : Israel Thrombosis Drugs Market Size (US$ Mn) Forecast, by Indication, 2016–2026
  • Table 81 : Israel Thrombosis Drugs Market Size (US$ Mn) Forecast, by Distribution Channel, 2016–2026
  • Table 82 : Rest of Middle East & Africa Thrombosis Drugs Market Size (US$ Mn) Forecast, by Drug Class, 2016–2026
  • Table 83 : Rest of Middle East & Africa Thrombosis Drugs Market Size (US$ Mn) Forecast, by Indication, 2016–2026
  • Table 84 : Rest of Middle East & Africa Thrombosis Drugs Market Size (US$ Mn) Forecast, by Distribution Channel, 2016–2026
  • Figure 1 : Global Thrombosis Drugs Market Size (US$ Mn) Forecast, 2016–2026
  • Figure 2 : Global Thrombosis Drugs Y-o-Y Growth Rate (%), 2017–2026
  • Figure 3 : Market Value Share, by Drug Class (2017)
  • Figure 4 : Market Value Share, by Indication (2017)
  • Figure 5 : Market Value Share, by Distribution Channel (2017)
  • Figure 7 : Global Thrombosis Drugs Market, by Drug Product, 2017 and 2026
  • Figure 8 : Global Thrombosis Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Factor Xa Inhibitor, 2016–2026
  • Figure 9 : Global Thrombosis Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Low Molecular Weight Heparin, 2016–2026
  • Figure 10 : Global Thrombosis Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by P2Y12 Platelet Inhibitor, 2016–2026
  • Figure 11 : Global Thrombosis Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Others, 2016–2026
  • Figure 12 : Global Thrombosis Drugs Market Attractiveness, by Drug Class, 2018–2025
  • Figure 13 : Global Thrombosis Drugs Market, by Indication, 2017 and 2026
  • Figure 14 : Global Thrombosis Drugs Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Indication: Pulmonary Embolism, 2016–2026
  • Figure 15 : Global Thrombosis Drugs Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Indication: Atrial Fibrillation, 2016–2026
  • Figure 16 : Global Thrombosis Drugs Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Indication: Deep Vein Thrombosis, 2016–2026
  • Figure 17 : Global Thrombosis Drugs Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Indication: Others, 2016–2026
  • Figure 18 : Global Thrombosis Drugs Market Attractiveness, by Indication, 2018–2025
  • Figure 19 : Global Thrombosis Drugs Market, by Distribution Channel, 2017 and 2026
  • Figure 20 : Global Thrombosis Drugs Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Distribution Channel: Hospital Pharmacies, 2016–2026
  • Figure 21 : Global Thrombosis Drugs Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Distribution Channel: Retail Pharmacies, 2016–2026
  • Figure 22 : Global Thrombosis Drugs Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Distribution Channel: Online Pharmacies, 2016–2026
  • Figure 23 : Global Thrombosis Drugs Market Attractiveness, by Distribution Channel, 2018–2025
  • Figure 24 : Global Thrombosis Drugs Market Value Share, by Region, 2017 and 2026
  • Figure 25 : Thrombosis Drugs Market Attractiveness Analysis, by Region, 2017–2026
  • Figure 26 : North America Thrombosis Drugs Market Size (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2016–2026
  • Figure 27 : North America Thrombosis Drugs Market Value Share, by Country, 2017 and 2026
  • Figure 28 : North America Thrombosis Drugs Market Attractiveness, by Country, 2017–2026
  • Figure 29 : North America Thrombosis Drugs Market Value Share, by Drug Class, 2017 and 2026
  • Figure 30 : North America Thrombosis Drugs Market Attractiveness, by Drug Class, 2017–2026
  • Figure 31 : North America Thrombosis Drugs Market Value Share, by Indication, 2017 and 2026
  • Figure 32 : North America Thrombosis Drugs Market Attractiveness, by Indication, 2017–2026
  • Figure 33 : North America Thrombosis Drugs Market Value Share, by Distribution Channel, 2017 and 2026
  • Figure 34 : North America Thrombosis Drugs Market Attractiveness, by Distribution Channel, 2017–2026
  • Figure 35 : Europe Thrombosis Drugs Market Size (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2016–2026
  • Figure 36 : Europe Thrombosis Drugs Market Value Share, by Country/Sub-region, 2017 and 2026
  • Figure 37 : Europe Thrombosis Drugs Market Attractiveness, by Country/Sub-region, 2017–2026
  • Figure 38 : Europe Thrombosis Drugs Market Value Share, by Drug Class, 2017 and 2026
  • Figure 39 : Europe Thrombosis Drugs Market Attractiveness, by Drug Class, 2017–2026
  • Figure 40 : Europe Thrombosis Drugs Market Value Share, Indication, 2017 and 2026
  • Figure 41 : Europe Thrombosis Drugs Market Attractiveness Analysis, Indication, 2017–2026
  • Figure 42 : Europe Thrombosis Drugs Market Value Share, Distribution Channel, 2017 and 2026
  • Figure 43 : Europe Thrombosis Drugs Market Attractiveness Analysis, Distribution Channel, 2017–2026
  • Figure 44 : Asia Pacific Thrombosis Drugs Market Size (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2016–2026
  • Figure 45 : Asia Pacific Thrombosis Drugs Market Value Share, by Country/Sub-region, 2017 and 2026
  • Figure 46 : Asia Pacific Thrombosis Drugs Market Attractiveness, by Country/Sub-region, 2017–2026
  • Figure 47 : Asia Pacific Thrombosis Drugs Market Value Share, by Drug Class, 2017 and 2026
  • Figure 48 : Asia Pacific Thrombosis Drugs Market Attractiveness, by Drug Class, 2017–2026
  • Figure 49 : Asia Pacific Thrombosis Drugs Market Value Share, Indication, 2017 and 2026
  • Figure 50 : Asia Pacific Thrombosis Drugs Market Attractiveness Analysis, Indication, 2017–2026
  • Figure 51 : Asia Pacific Thrombosis Drugs Market Value Share, Distribution Channel, 2017 and 2026
  • Figure 52 : Asia Pacific Thrombosis Drugs Market Attractiveness Analysis, Distribution Channel, 2017–2026
  • Figure 53 : Latin America Thrombosis Drugs Market Size (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2016–2026
  • Figure 54 : Latin America Thrombosis Drugs Market Value Share, by Country/Sub-region, 2017 and 2026
  • Figure 55 : Latin America Thrombosis Drugs Market Attractiveness, by Country/Sub-region, 2017–2026
  • Figure 56 : Latin America Thrombosis Drugs Market Value Share, by Drug Class, 2017 and 2026
  • Figure 57 : Latin America Thrombosis Drugs Market Attractiveness, by Drug Class, 2017–2026
  • Figure 58 : Latin America Thrombosis Drugs Market Value Share, Indication, 2017 and 2026
  • Figure 59 : Latin America Thrombosis Drugs Market Attractiveness Analysis, Indication, 2017–2026
  • Figure 60 : Latin America Thrombosis Drugs Market Value Share, Distribution Channel, 2017 and 2026
  • Figure 61 : Latin America Thrombosis Drugs Market Attractiveness Analysis, Distribution Channel, 2017–2026
  • Figure 62 : Middle East & Africa Thrombosis Drugs Market Size (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2016–2026
  • Figure 63 : Middle East & Africa Thrombosis Drugs Market Value Share, by Country/Sub-region, 2017 and 2026
  • Figure 64 : Middle East & Africa Thrombosis Drugs Market Attractiveness, by Country/Sub-region, 2017–2026
  • Figure 65 : Middle East & Africa Thrombosis Drugs Market Value Share, by Drug Class, 2017 and 2026
  • Figure 66 : Middle East & Africa Thrombosis Drugs Market Attractiveness, by Drug Class, 2017–2026
  • Figure 67 : Middle East & Africa Thrombosis Drugs Market Value Share, Indication, 2017 and 2026
  • Figure 68 : Middle East & Africa Thrombosis Drugs Market Attractiveness Analysis, Indication, 2017–2026
  • Figure 69 : Middle East & Africa Thrombosis Drugs Market Value Share, Distribution Channel, 2017 and 2026
  • Figure 70 : Middle East & Africa Thrombosis Drugs Market Attractiveness Analysis, Distribution Channel, 2017–2026

Leaders in analytics, research and advisory services for Fortune 500 companies, scores of high potential startups, and financial institutions. Our success stories have proven why we are a prominent provider of a cutting-edge syndicated and customized research services. Leverage the best of our seasoned research analysts who had a keen interest and enviable expertise of almost 4 million hours in global, regional, and local market intelligence.

Why BCC Research?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
CUSTOM RESEARCH

Need a custom data table, graph or complete report? Tell us more.

Contact Us
Share This Report